Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Save Sight Now To Reduce Costs Later
Eye disease and sight loss cost the UK nearly ÷£6.5bn in 2008, according to new research** which informs, "Cost Oversight", a report due later this summer from the Royal National Institute of Blind People (RNIB). In addition, research found that the impact on quality of life (including loss of healthy life and premature death) associated with partial sight and blindness also has a cost to society, estimated at a further ÷£15.5bn in 2008.
generic viagra online
AAMC Commends Final National Institutes of Health's Stem Cell Guidelines
AAMC (Association of American Medical Colleges) President and CEO Darrell G. Kirch, M.D., issued the following statement on the final National Institutes of Health"s (NIH) Guidelines on Human Stem Research, published today:
plastic surgery before after
News of the day
Few Retail Health Clinics Located In Low-Income Areas, Study Finds
Most retail health clinics are located in more affluent areas of the U.S., rather than in low-income, medically underserved neighborhoods, according to a study published on Monday in the Archives of Internal Medicine, the AP/Washington Times reports. For the study, researchers mapped 930 retail clinics operating in 2008 and used U.S. census data to evaluate the overall income and racial characteristics of the neighborhoods where clinics were located. In counties with at least one retail health clinic, researchers compared census areas with and without retail clinics. According to the study, 123 clinics were in communities classified by the federal government as medically underserved. Communities with clinics had lower percentages of black and Hispanic residents, lower poverty rates, higher homeownership rates and higher median incomes, according to the study.Ateev Mehrotra of the University of Pittsburgh said, "Many people have promoted retail clinics as a cure for access to care for the underserved," adding, "These findings show that"s unlikely to happen." Lead study author Craig Pollack of the University of Pennsylvania said the study"s results suggest financial incentives might be needed to bring clinics to low-income communities (Johnson, AP/Washington Times, 5/26).
Endocrinology

Mylan Receives FDA Approval For Generic Version Of Thyroid Deficiency Treatment Cytomel(R)

Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Liothyronine Sodium Tablets USP, 5 mcg (base), 25 mcg (base) and 50 mcg (base). Liothyronine Sodium Tablets are the generic version of King Pharmaceuticals" thyroid deficiency treatment Cytomel(R), which had total U.S. sales of approximately $54 million for the 12 months ending March 31 for the same strengths, according to IMS Health. Mylan has begun to ship this product. Currently, Mylan has 120 ANDAs pending FDA approval representing $84.7 billion in annual brand sales, according to IMS Health. Thirty-five of these pending ANDAs are potential first-to-file opportunities, representing $16.6 billion in annual brand sales, according to IMS Health. Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generics and specialty pharmaceutical companies in the world. The company maintains one of the industry"s broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world"s third largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. Mylan Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009